Nesiritide recombinant - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for nesiritide recombinant and what is the scope of freedom to operate?
Nesiritide recombinant
is the generic ingredient in one branded drug marketed by Scios Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for nesiritide recombinant
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 62 |
DailyMed Link: | nesiritide recombinant at DailyMed |
Recent Clinical Trials for nesiritide recombinant
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Vanderbilt University Medical Center | Phase 3 |
AstraZeneca | Phase 3 |
Vanderbilt University Medical Center | Phase 4 |
US Patents and Regulatory Information for nesiritide recombinant
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scios Llc | NATRECOR | nesiritide recombinant | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for nesiritide recombinant
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Scios Llc | NATRECOR | nesiritide recombinant | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Scios Llc | NATRECOR | nesiritide recombinant | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Scios Llc | NATRECOR | nesiritide recombinant | FOR SOLUTION;INTRAVENOUS | 020920-001 | Aug 10, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |